Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose

Musbah O. Tanira, Mohammed K. Al-Mukhaini, Ali T. Al-Hinai, Khalid A. Al Balushi, Ikhlas S. Ahmed

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. Methods: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups of continuous data for significance differences. Results: Genotyping data showed that 12.7 and 5.8% of the samples were heterozygous for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C9*2 allele frequency was 0.074 in our population. It was 0.029 for CYP2C9*3. Conclusion: This is the first report on the presence of CYP2C9*2 allele homozygocity in any Asian or African population.

Original languageEnglish
Pages (from-to)32-37
Number of pages6
JournalCommunity Genetics
Volume10
Issue number1
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Warfarin
Genotype
Gene Frequency
Alleles
Population
Cytochrome P-450 CYP2C9
Restriction Fragment Length Polymorphisms
Polymerase Chain Reaction

Keywords

  • CYP2C9 genotype
  • Warfarin treatment

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose. / Tanira, Musbah O.; Al-Mukhaini, Mohammed K.; Al-Hinai, Ali T.; Al Balushi, Khalid A.; Ahmed, Ikhlas S.

In: Community Genetics, Vol. 10, No. 1, 12.2006, p. 32-37.

Research output: Contribution to journalArticle

@article{bdfaa51580eb41019164ac5f9c1b83cb,
title = "Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose",
abstract = "Objectives: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. Methods: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups of continuous data for significance differences. Results: Genotyping data showed that 12.7 and 5.8{\%} of the samples were heterozygous for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C9*2 allele frequency was 0.074 in our population. It was 0.029 for CYP2C9*3. Conclusion: This is the first report on the presence of CYP2C9*2 allele homozygocity in any Asian or African population.",
keywords = "CYP2C9 genotype, Warfarin treatment",
author = "Tanira, {Musbah O.} and Al-Mukhaini, {Mohammed K.} and Al-Hinai, {Ali T.} and {Al Balushi}, {Khalid A.} and Ahmed, {Ikhlas S.}",
year = "2006",
month = "12",
doi = "10.1159/000096279",
language = "English",
volume = "10",
pages = "32--37",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose

AU - Tanira, Musbah O.

AU - Al-Mukhaini, Mohammed K.

AU - Al-Hinai, Ali T.

AU - Al Balushi, Khalid A.

AU - Ahmed, Ikhlas S.

PY - 2006/12

Y1 - 2006/12

N2 - Objectives: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. Methods: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups of continuous data for significance differences. Results: Genotyping data showed that 12.7 and 5.8% of the samples were heterozygous for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C9*2 allele frequency was 0.074 in our population. It was 0.029 for CYP2C9*3. Conclusion: This is the first report on the presence of CYP2C9*2 allele homozygocity in any Asian or African population.

AB - Objectives: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. Methods: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups of continuous data for significance differences. Results: Genotyping data showed that 12.7 and 5.8% of the samples were heterozygous for the CYP2C9*2 and CYP2C9*3 alleles, respectively. The CYP2C9*2 allele frequency was 0.074 in our population. It was 0.029 for CYP2C9*3. Conclusion: This is the first report on the presence of CYP2C9*2 allele homozygocity in any Asian or African population.

KW - CYP2C9 genotype

KW - Warfarin treatment

UR - http://www.scopus.com/inward/record.url?scp=33845765706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845765706&partnerID=8YFLogxK

U2 - 10.1159/000096279

DO - 10.1159/000096279

M3 - Article

VL - 10

SP - 32

EP - 37

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

IS - 1

ER -